• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IV 期非贲门胃癌患者的生存 - DNA 倍体和幽门螺杆菌感染的影响。

Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection.

机构信息

Department of Pathophysiology, Oncology Unit, Laikon General Hospital, Athens University School of Medicine, Athens, Greece.

出版信息

BMC Cancer. 2012 Jun 21;12:264. doi: 10.1186/1471-2407-12-264.

DOI:10.1186/1471-2407-12-264
PMID:22892134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3434083/
Abstract

BACKGROUND

Palliative surgery followed by postoperative chemotherapy is a challenging approach in the treatment of stage IV gastric cancer yet patients must be carefully selected on the basis of likely clinical benefit.

METHODS

The records of 218 patients with histological diagnosis of gastric adenocarcinoma who underwent palliative surgery followed by postoperative chemotherapy were retrospectively reviewed. Twelve potential prognostic variables including tumour DNA index and serum IgG anti- Helicobacter pylori (HP) antibodies were evaluated for their influence on overall survival by multivariate analysis.

RESULTS

The median survival was 13.25 months [95% Confidence Interval (CI) 12.00, 14.50]. Three factors were found to have an independent effect on survival: performance status (PS) [PS 60-70 vs. 90-100 Hazard Ratio (HR) 1.676; CI 1.171-2.398, p = 0.005], liver metastases (HR 1.745; CI 1.318-2.310, p < 0.001), and DNA Index as assessed by Image cytometry (2.2-3.6 vs. >3.6 HR 3.059; CI 2.185-4.283, p < 0.001 and <2.2 vs. >3.6 HR; 4.207 CI 2.751-6.433 <0.001). HP infection had no statistically significant effect on survival by either univariate or multivariate analysis.

CONCLUSION

Poor pre-treatment PS, the presence of liver metastasis and high DNA Index were identified factors associated with adverse survival outcome in patients with Stage IV gastric cancer treated with palliative gastrectomy and postoperative chemotherapy. HP infection had no influence on survival of these patients.

摘要

背景

姑息性手术加术后化疗是治疗 IV 期胃癌的一种具有挑战性的方法,但必须根据可能的临床获益仔细选择患者。

方法

回顾性分析了 218 例经组织学诊断为胃腺癌并接受姑息性手术加术后化疗的患者的病历。通过多变量分析评估了 12 个潜在的预后变量(包括肿瘤 DNA 指数和血清 IgG 抗幽门螺杆菌(HP)抗体)对总生存期的影响。

结果

中位生存期为 13.25 个月[95%置信区间(CI)12.00,14.50]。发现 3 个因素对生存有独立影响:体能状态(PS)[PS 60-70 与 90-100 HR 1.676;CI 1.171-2.398,p=0.005]、肝转移(HR 1.745;CI 1.318-2.310,p<0.001)和图像细胞术评估的 DNA 指数(2.2-3.6 与>3.6 HR 3.059;CI 2.185-4.283,p<0.001 和<2.2 与>3.6 HR;4.207 CI 2.751-6.433 <0.001)。HP 感染无论在单变量还是多变量分析中均未对生存产生统计学显著影响。

结论

在接受姑息性胃切除术和术后化疗治疗的 IV 期胃癌患者中,较差的治疗前 PS、肝转移和高 DNA 指数是与不良生存结果相关的因素。HP 感染对这些患者的生存没有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/5b3ec0c5c7a3/1471-2407-12-264-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/6d59fc620951/1471-2407-12-264-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/d8d6503db21e/1471-2407-12-264-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/71485826be6e/1471-2407-12-264-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/5b3ec0c5c7a3/1471-2407-12-264-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/6d59fc620951/1471-2407-12-264-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/d8d6503db21e/1471-2407-12-264-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/71485826be6e/1471-2407-12-264-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/252a/3434083/5b3ec0c5c7a3/1471-2407-12-264-4.jpg

相似文献

1
Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection.IV 期非贲门胃癌患者的生存 - DNA 倍体和幽门螺杆菌感染的影响。
BMC Cancer. 2012 Jun 21;12:264. doi: 10.1186/1471-2407-12-264.
2
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years.胃大部切除术后根除幽门螺杆菌对胃癌患者生存率的影响:长达15年的随访
Gastric Cancer. 2020 Nov;23(6):1051-1063. doi: 10.1007/s10120-020-01076-2. Epub 2020 May 2.
3
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.幽门螺杆菌根除对胃癌远端胃切除术后长期生存的影响。
Cancer Res Treat. 2016 Jul;48(3):1020-9. doi: 10.4143/crt.2015.264. Epub 2015 Nov 17.
4
Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma.术前幽门螺杆菌感染与胃腺癌切除术后生存率提高相关。
Ann Surg Oncol. 2016 Apr;23(4):1225-33. doi: 10.1245/s10434-015-4953-x. Epub 2015 Nov 9.
5
DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.DNA 倍性:转移性胃腺癌化疗反应和生存的预后因素。
Anticancer Res. 2013 Mar;33(3):1209-14.
6
Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.预测接受姑息性胃切除术的转移性胃腺癌患者生存的列线图。
BMC Cancer. 2019 Aug 28;19(1):852. doi: 10.1186/s12885-019-6075-5.
7
[Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].42例原发性胃腺鳞癌患者的临床病理特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):207-212.
8
Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.ypTNM 分期和 pTNM 分期对胃癌预后的不同影响:倾向评分匹配分析。
BMC Cancer. 2019 Jan 16;19(1):80. doi: 10.1186/s12885-019-5283-3.
9
[Prognostic factors of lymph node-negative metastasis gastric cancer].[淋巴结阴性转移性胃癌的预后因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194.
10
Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival.高胃泌素血症与胃体腺癌及患者较短生存期相关。
APMIS. 2015 Jun;123(6):509-14. doi: 10.1111/apm.12380. Epub 2015 May 5.

引用本文的文献

1
Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis.幽门螺杆菌阳性状态预测非贲门胃癌患者预后更好:来自队列研究和荟萃分析的结果。
BMC Cancer. 2022 Feb 8;22(1):155. doi: 10.1186/s12885-022-09222-y.
2
Survival of gastric cancer patients based on pathologic and demographic characteristics in Mazandaran between 2007 and 2013.基于2007年至2013年马赞德兰省胃癌患者的病理和人口统计学特征的生存率
Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):315-321.
3
Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.

本文引用的文献

1
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.采用 ELISA 和免疫印迹法评估幽门螺杆菌感染与非贲门胃癌风险的前瞻性研究:Eurgast-EPIC 项目。
Ann Oncol. 2012 May;23(5):1320-1324. doi: 10.1093/annonc/mdr384. Epub 2011 Sep 14.
2
Helicobacter pylori Infection and Gastric Adenocarcinoma.幽门螺杆菌感染与胃腺癌
US Gastroenterol Hepatol Rev. 2011 Jun;7(1):59-64.
3
Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection.
胃癌中 DNA 非整倍体的预后价值:3449 例病例的荟萃分析。
BMC Cancer. 2019 Jul 2;19(1):650. doi: 10.1186/s12885-019-5869-9.
4
Activation of CD3 T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma.利用幽门螺杆菌 DNA 疫苗激活 CD3 T 细胞,为胃癌的潜在免疫治疗提供可能。
Cancer Biol Ther. 2019;20(6):866-876. doi: 10.1080/15384047.2019.1579957. Epub 2019 Feb 20.
5
Clinical Influence of Ploidy and Cancer Stem Cells and Other Parameters in Stage IV Colorectal Cancer.倍性、癌症干细胞及其他参数对IV期结直肠癌的临床影响
In Vivo. 2019 Jan-Feb;33(1):245-249. doi: 10.21873/invivo.11467.
6
Positive status is associated with better overall survival for gastric cancer patients: evidence from case-cohort studies.阳性状态与胃癌患者更好的总生存期相关:病例队列研究的证据。
Oncotarget. 2017 Jun 28;8(45):79604-79617. doi: 10.18632/oncotarget.18758. eCollection 2017 Oct 3.
7
Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.幽门螺杆菌感染对胃及胃食管交界部癌切除术后结局的影响。
J Gastrointest Oncol. 2017 Jun;8(3):583-588. doi: 10.21037/jgo.2017.01.22.
8
The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer.BRAF突变及其他分子、临床和实验室参数对IV期结直肠癌的预后影响
Pathol Oncol Res. 2016 Oct;22(4):707-14. doi: 10.1007/s12253-016-0056-7. Epub 2016 Mar 31.
9
The Effect of Helicobacter pylori on Gastric Cancer Treated with Adjuvant Chemotherapy After Curative Resection.幽门螺杆菌对根治性切除术后辅助化疗治疗胃癌的影响。
Indian J Surg. 2015 Dec;77(6):489-94. doi: 10.1007/s12262-015-1305-9. Epub 2015 Jun 23.
10
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer.血清幽门螺杆菌NapA抗体作为胃癌的潜在生物标志物。
Sci Rep. 2014 Feb 20;4:4143. doi: 10.1038/srep04143.
根治性切除术后辅助化疗的局部进展期胃癌患者中,幽门螺杆菌感染是一个独立的预后因素。
Int J Cancer. 2012 Feb 15;130(4):948-58. doi: 10.1002/ijc.26081. Epub 2011 May 25.
4
Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.姑息性胃切除术和其他因素对接受化疗的 IV 期胃腺癌患者总生存的影响:回顾性分析。
Eur J Surg Oncol. 2011 Apr;37(4):312-8. doi: 10.1016/j.ejso.2011.01.019.
5
DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic significance in imprints of non-small cell lung cancer.非小细胞肺癌印片中DNA倍体、E-钙黏蛋白、β-连环蛋白表达及其临床病理意义
Anal Quant Cytol Histol. 2009 Oct;31(5):332-9.
6
Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.幽门螺杆菌感染与胃癌临床病理特征及预后的关系。
BMC Cancer. 2010 Jul 17;10:374. doi: 10.1186/1471-2407-10-374.
7
Helicobacter pylori: gastric cancer and beyond.幽门螺杆菌:胃癌及其他。
Nat Rev Cancer. 2010 Jun;10(6):403-14. doi: 10.1038/nrc2857.
8
Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design.晚期胃癌多次挽救性化疗的结果:对临床实践和试验设计的启示。
Cancer Chemother Pharmacol. 2010 Sep;66(4):797-805. doi: 10.1007/s00280-010-1295-z. Epub 2010 Mar 11.
9
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.二线化疗治疗转移性胃癌患者的预后模型。
Ann Oncol. 2010 Sep;21(9):1779-1785. doi: 10.1093/annonc/mdq032. Epub 2010 Feb 11.
10
Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.通过DNA图像细胞术测量的基因组总体损伤可独立预测胃癌患者的生存率。
Br J Cancer. 2009 Sep 15;101(6):1011-8. doi: 10.1038/sj.bjc.6605266.